Transplantation of insulin-producing cells derived from umbilical cord stromal mesenchymal stem cells to treat NOD mice. 2011

Hwai-Shi Wang, and Jia-Fwu Shyu, and Wen-Sheng Shen, and Hsin-Chi Hsu, and Torng-Chien Chi, and Chie-Pein Chen, and Seng-Wong Huang, and Yi-Ming Shyr, and Kam-Tsun Tang, and Tien-Hua Chen
Institute of Anatomy and Cell Biology, School of Medicine, National Yang Ming University, Taipei, Taiwan, ROC.

Diabetes mellitus can be treated with islet transplantation, although there is a scarcity of donors. This study investigated whether human mesenchymal stem cells (MSCs) from umbilical cord stroma could be induced to differentiate into insulin-producing cells and the effects of retro-orbital injection of human insulin-producing cells for the treatment of nonobese diabetic (NOD) mice. MSCs were isolated from human umbilical cord stroma and induced to differentiate into insulin-producing cells using differentiation medium. Differentiated cells were evaluated by immunocytochemistry, RT-PCR, and real-time PCR. C-peptide release, both spontaneous and after glucose challenge, was measured by ELISA. Insulin-producing cells were then transplanted into NOD mice. Blood glucose levels and body weights were monitored weekly. Human nuclei and C-peptide were detected in mouse livers by immunohistochemistry. Pancreatic β-cell development-related genes were expressed in the differentiated insulin-producing cells. Differentiated cells' C-peptide release in vitro increased after glucose challenge. Further, in vivo glucose tolerance tests showed that blood sugar levels decreased after the cells' transplantation into NOD mice. After transplantation, insulin-producing cells containing human C-peptide and human nuclei were located in the liver. Thus, we demonstrated that differentiated insulin-producing cells from human umbilical cord stromal MSCs transplanted into NOD mice could alleviate hyperglycemia in diabetic mice.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008297 Male Males
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D002096 C-Peptide The middle segment of proinsulin that is between the N-terminal B-chain and the C-terminal A-chain. It is a pancreatic peptide of about 31 residues, depending on the species. Upon proteolytic cleavage of proinsulin, equimolar INSULIN and C-peptide are released. C-peptide immunoassay has been used to assess pancreatic beta cell function in diabetic patients with circulating insulin antibodies or exogenous insulin. Half-life of C-peptide is 30 min, almost 8 times that of insulin. Proinsulin C-Peptide,C-Peptide, Proinsulin,Connecting Peptide,C Peptide,C Peptide, Proinsulin,Proinsulin C Peptide
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D002467 Cell Nucleus Within a eukaryotic cell, a membrane-limited body which contains chromosomes and one or more nucleoli (CELL NUCLEOLUS). The nuclear membrane consists of a double unit-type membrane which is perforated by a number of pores; the outermost membrane is continuous with the ENDOPLASMIC RETICULUM. A cell may contain more than one nucleus. (From Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed) Cell Nuclei,Nuclei, Cell,Nucleus, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003922 Diabetes Mellitus, Type 1 A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence. Diabetes Mellitus, Brittle,Diabetes Mellitus, Insulin-Dependent,Diabetes Mellitus, Juvenile-Onset,Diabetes Mellitus, Ketosis-Prone,Diabetes Mellitus, Sudden-Onset,Diabetes, Autoimmune,IDDM,Autoimmune Diabetes,Diabetes Mellitus, Insulin-Dependent, 1,Diabetes Mellitus, Type I,Insulin-Dependent Diabetes Mellitus 1,Juvenile-Onset Diabetes,Type 1 Diabetes,Type 1 Diabetes Mellitus,Brittle Diabetes Mellitus,Diabetes Mellitus, Insulin Dependent,Diabetes Mellitus, Juvenile Onset,Diabetes Mellitus, Ketosis Prone,Diabetes Mellitus, Sudden Onset,Diabetes, Juvenile-Onset,Diabetes, Type 1,Insulin Dependent Diabetes Mellitus 1,Insulin-Dependent Diabetes Mellitus,Juvenile Onset Diabetes,Juvenile-Onset Diabetes Mellitus,Ketosis-Prone Diabetes Mellitus,Sudden-Onset Diabetes Mellitus
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose

Related Publications

Hwai-Shi Wang, and Jia-Fwu Shyu, and Wen-Sheng Shen, and Hsin-Chi Hsu, and Torng-Chien Chi, and Chie-Pein Chen, and Seng-Wong Huang, and Yi-Ming Shyr, and Kam-Tsun Tang, and Tien-Hua Chen
April 2017, Experimental and therapeutic medicine,
Hwai-Shi Wang, and Jia-Fwu Shyu, and Wen-Sheng Shen, and Hsin-Chi Hsu, and Torng-Chien Chi, and Chie-Pein Chen, and Seng-Wong Huang, and Yi-Ming Shyr, and Kam-Tsun Tang, and Tien-Hua Chen
July 2022, Stem cell research & therapy,
Hwai-Shi Wang, and Jia-Fwu Shyu, and Wen-Sheng Shen, and Hsin-Chi Hsu, and Torng-Chien Chi, and Chie-Pein Chen, and Seng-Wong Huang, and Yi-Ming Shyr, and Kam-Tsun Tang, and Tien-Hua Chen
January 2012, Cell transplantation,
Hwai-Shi Wang, and Jia-Fwu Shyu, and Wen-Sheng Shen, and Hsin-Chi Hsu, and Torng-Chien Chi, and Chie-Pein Chen, and Seng-Wong Huang, and Yi-Ming Shyr, and Kam-Tsun Tang, and Tien-Hua Chen
November 2016, International journal of stem cells,
Hwai-Shi Wang, and Jia-Fwu Shyu, and Wen-Sheng Shen, and Hsin-Chi Hsu, and Torng-Chien Chi, and Chie-Pein Chen, and Seng-Wong Huang, and Yi-Ming Shyr, and Kam-Tsun Tang, and Tien-Hua Chen
May 2011, Chinese medical journal,
Hwai-Shi Wang, and Jia-Fwu Shyu, and Wen-Sheng Shen, and Hsin-Chi Hsu, and Torng-Chien Chi, and Chie-Pein Chen, and Seng-Wong Huang, and Yi-Ming Shyr, and Kam-Tsun Tang, and Tien-Hua Chen
December 2005, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi,
Hwai-Shi Wang, and Jia-Fwu Shyu, and Wen-Sheng Shen, and Hsin-Chi Hsu, and Torng-Chien Chi, and Chie-Pein Chen, and Seng-Wong Huang, and Yi-Ming Shyr, and Kam-Tsun Tang, and Tien-Hua Chen
August 2002, Experimental hematology,
Hwai-Shi Wang, and Jia-Fwu Shyu, and Wen-Sheng Shen, and Hsin-Chi Hsu, and Torng-Chien Chi, and Chie-Pein Chen, and Seng-Wong Huang, and Yi-Ming Shyr, and Kam-Tsun Tang, and Tien-Hua Chen
February 2010, Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae,
Hwai-Shi Wang, and Jia-Fwu Shyu, and Wen-Sheng Shen, and Hsin-Chi Hsu, and Torng-Chien Chi, and Chie-Pein Chen, and Seng-Wong Huang, and Yi-Ming Shyr, and Kam-Tsun Tang, and Tien-Hua Chen
October 2015, Biochemical and biophysical research communications,
Hwai-Shi Wang, and Jia-Fwu Shyu, and Wen-Sheng Shen, and Hsin-Chi Hsu, and Torng-Chien Chi, and Chie-Pein Chen, and Seng-Wong Huang, and Yi-Ming Shyr, and Kam-Tsun Tang, and Tien-Hua Chen
January 2023, Heliyon,
Copied contents to your clipboard!